SCHEMBL4695758

SCHEMBL4695758

Oc1ccc(CCNCC2CCc3ccccc3C2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.73
ADRA1A P35348 1/20 0.73
ADRA1B P35368 1/20 0.73
ALDH1A1 P00352 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
TP53 P04637 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
MAPT P10636 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
GRIN2B Q13224 4/20 0.49
HTR1D P28221 2/20 0.46
HTR1A P08908 1/20 0.46
HTR2A P28223 1/20 0.46
HRH1 P35367 1/20 0.46
POLB P06746 1/20 0.45
KMT2A Q03164 1/20 0.45
HTR1B P28222 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9082016 0.90 ADRA1D (0.74) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL9082586 0.88 ADRA1D (0.71) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL9082550 0.88 ADRA1D (0.71) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL9085175 0.88 ADRA1D (0.71) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL9081216 0.85 ADRA1D (0.61) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL7034334 0.84 ADRA1D (1.00) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL9288534 0.82 ADRA1D (0.78) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL9082023 0.82 ADRA1D (0.64) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL9083932 0.82 ADRA1A (0.64) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL9513250 0.80 ADRA1D (0.65) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109542-A4 NITROSATED AND NITROSYLATED ALPHA-ADRENERGIC RECEPTOR ANTAGONISTS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2008-03-26 EP disclosed
EP-1109542-A1 NITROSATED AND NITROSYLATED ALPHA-ADRENERGIC RECEPTOR ANTAGONISTS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2001-06-27 EP disclosed
WO-2000012075-A1 NITROSATED AND NITROSYLATED ALPHA-ADRENERGIC RECEPTOR ANTAGONISTS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2000-03-09 WO disclosed
US-5508306-A USED FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA, LOWERING INTRAOCULAR PRESSURE AND INHIBITING CHOLESTEROL SYNTHESIS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1996-04-16 US disclosed
WO-1995007075-A9 NOVEL AROMATIC AMINE DERIVATIVES 1995-04-27 WO disclosed